Ole Miss Students' Deaths Spark Federal Probe Over Packaging Found
Two Ole Miss students died on Sept. 21 at separate locations, sparking a federal probe into potential foul play. Aidan Hamilton was 18, while Robert Strang was 20. Initial news reports claimed investigators found "packaged kratom" or "synthetic kratom" near the bodies. That narrative shifted quickly. A statement released by Lafayette County Metro Narcotics on Sept. 30 clarified that only packaging associated with kratom-related products was recovered. The medical examiner has not yet released toxicology results, so the cause of death remains officially pending.
Court documents reveal specific details about what police found. Tablets labeled Smax Pseudo-DHM were present at both scenes. Ingredients listed on those packs included pseudoindoxyl and MGM-15(DHM). Mac Haddow, a senior fellow for public policy with the American Kratom Association in Virginia, told Fox News Digital that the initial characterization was deeply concerning to his organization. He argued it is statistically improbable that natural kratom leaves caused two independent deaths. After reaching out to Oxford police without success, the association held a press conference demanding answers from officials about why they disclosed such packaging.
The clarification came fast enough to ease some fears. Officials confirmed the recovered items were chemically manipulated opioids rather than traditional herbal extracts. Haddow noted these substances are controlled under the Federal Controlled Substances Act. He stated those specific products never should have been sold in Mississippi. The state operates under the Mississippi Kratom Consumer Protection Act, which regulates sales but does not ban kratom entirely. This law sets standards for sellers and requires clear labeling while prohibiting adulterated or high-potency items. Haddow asked why regulators were not enforcing these rules before the tragedy occurred.

Natural kratom leaves have been used for centuries in Southeast Asia without published reports of fatal overdoses linked to traditional use there. Medical literature does note some adverse effects from long-term consumption, however. According to Haddow, the substance entered the U.S. market after the Vietnam War when returning soldiers and immigrants brought it back home. The distinction between natural leaf products and modern synthetics is becoming a central point of debate as authorities investigate whether negligence or malice led to these deaths.
Experts say the story behind how kratom became a federal target lacks solid proof in the published scientific record.
"And then these amateur chemists got involved and started tinkering with the alkaloids in the natural plant and started to adulterate them, and that appropriately got kratom on the radar of both the DEA and the FDA," he said.

The trouble began quietly but escalated fast. In 2012, the FDA issued an import alert on kratom products, signaling immediate concern over what was flowing across borders. By 2016, the DEA sought to temporarily classify kratom's primary alkaloids as Schedule I substances before withdrawing the proposal following public comment.
More recently, the agencies have raised concerns about concentrated and chemically modified kratom products, including those containing high levels of 7-hydroxymitragynine (7-OH).
"What these bad actors have done is completely alter the composition of the natural kratom plant," Haddow said.

"They rearranged the molecules. They've chemically synthesized them with high-concentration chlorine and baking soda and other nefarious production methods, so that they deliver what is in fact a signature opioid to consumers in the United States."
Haddow pointed out that calls for stronger enforcement now focus on banning synthetic products while protecting the natural leaf.
"It is improper for any government agency across the country to be blaming natural leaf kratom for any adverse event that is properly attributable to a synthetic opioid," he added, expressing his viewpoint clearly.

"If we were to take coffee and extract caffeine from it and then highly concentrate it to a level in which it is fatal and someone ingested it and died, we wouldn't blame coffee, we would blame the bad actor that took and extracted that caffeine, because caffeine is in its natural form and coffee is not dangerous. The same is true for natural kratom."
Haddow said 7-hydroxymitragynine (7-OH) products, including Sudendoxyl and compounds known as MGM-15 and MGM-16, should not be considered kratom at all.
"[They] are synthetic opioids, all of which should be enforced by both the federal and local law enforcement agencies," he said.

"We advocate strongly for proper clarification of these dangerous products as opposed to natural kratom, which is literally helping people with their health and wellness and saving lives."
Haddow cited an NIH-led study that is moving forward to evaluate whether purified mitragynine, the main alkaloid in the kratom plant, could help treat opioid use disorder.
The association supports state regulations that require testing, labeling and age restrictions rather than outright bans.

"Make sure the product formulations are safe, make sure the products are labeled correctly and make sure they're age-restricted," he urged. "21 and up should be the only people who have access to these products."
"We need to regulate them, and as we represent consumers, we're going to fight for that."
The FDA maintains that kratom has not been approved for any medical use and has warned of some risks, including dependence, contamination and adverse events, while researchers continue to study both the plant and its individual compounds.
Photos